Original ArticleThe utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancer☆
References (0)
Cited by (86)
A new tool for technical standardization of the Ki67 immunohistochemical assay
2021, Modern PathologyPotential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors
2020, Pathology Research and PracticeCDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
2018, Pharmacology and TherapeuticsAssessment and designation of breast cancer stage
2018, The Breast: Comprehensive Management of Benign and Malignant DiseasesMolecular Subtypes and Local-Regional Control of Breast Cancer
2018, Surgical Oncology Clinics of North America
- ☆
The authors are from the European Organization for Research and Treatment of Cancer, EORTC Breast Cancer Co-operative Group.
- f2
Correspondence to: Marc J. van de Vijver, MD, PhD, Netherlands Cancer Institute, Department of Pathology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Fax: +31-20-512 27 59, E-mail: [email protected]
Copyright © 1999 Published by Elsevier Ltd. All rights reserved.